COVID-19 ICUs Life Support Equipment Market Growth. Up To $30 Billion per Annum
WASHINGTON, June 29, 2020 /PRNewswire/ -- HSRC announces the publication of its research report, "COVID-19 ICU (Noninvasive Ventilators, Invasive Mechanical Ventilators, Next Generation Ventilators, COVID-19 Homecare Equipment, Portable Ventilators, Surge Capacity Hospitals, Kidney Dialysis, Extracorporeal Membrane Oxygenation) Market -2024".
/PRNewswire/ --According to the report, the booming COVID-19 ICUs life support equipment market size will reach up to $30 Billion per Annum and the COVID-19 related ICU 2020-2024 cumulative market share will be 4.5%-8.3 % of the total COVID-19 pandemic mitigation products market.
The COVID-19 pandemic has led to acute deficiencies of essential ICU equipment and services from invasive mechanical ventilators and noninvasive ventilators to COVID-19 homecare equipment and portable ventilators. Never have the global leading healthcare communities been faced with the likelihood of having to use a ventilator for two patients or function without critical medical equipment on this magnitude.
At present, ventilation is about the only way ICU teams have to treat those who are seriously ill from COVID-19, and a shortage of available machines at the second surge of the pandemic is terrifying in many countries.
Absences of other medical products and consumables may lead to deaths, in most cases it will be the blended impacts of a variety of shortages that will result in harsher consequences. Invasive ventilation is unique. When patients' breathing worsens to the point that the patients could not do with an invasive mechanical ventilator, there is a limited window of time during which he-she can be saved. And when the ventilator is removed from a patient who is totally ventilation dependent, the patient will normally die within minutes.
During 2020, dozens of entrepreneurs, companies and organizations had entered the ventilators market. Most of the new entrants failed. Companies that have deployed their solutions later have seen their pandemic related non-invasive ventilator projects underperform in terms of return on investment (ROI) expectations.
Last but not least, governments in anticipation of the next pandemic surge will aggressively stockpile a strategic storage of non-invasive ventilators.
The COVID-19 Pandemic Mitigation Products Market - 2020-2024 report includes 54 sub-reports including the following nine COVID-19 related ICU sub-reports:
- Noninvasive Ventilators
- Invasive Mechanical Ventilators
- Next Generation Ventilators
- COVID-19 Homecare (Equipment, Software, Services)
- Portable Ventilators
- Surge Capacity Hospitals & ICUs
- Kidney Dialysis
- Extracorporeal Membrane Oxygenation Procedures
- Other ICU Modalities
According to the July 1, 2020 report update, the cumulative 2020-2024 Global COVID-19 Pandemic Mitigation Products Market* is forecasted to reach $1.6 – 2.1 Trillion.
This 1020-page 5-volume market mega report is the first and most comprehensive review of the new global COVID-19 Pandemic Mitigation Products & Services market available today. The "COVID-19 Pandemic Mitigation Products Market - 2020-2024" report presents a thorough market analysis of 54 products & services sub-reports, 6 vertical, 4 revenue source, 5 regional and 13 national markets providing in-depth analysis of this newly formed market.
View the comprehensive TOC of this report to browse through 5 volumes of market data, spanning over 1,020 pages, including 728 tables & figures and 212 submarkets - download TOC
The objective of this report is to provide today's strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market and provides answers to questions such as:
- What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecasted trends during 2020-2024?
- What are the most attractive business opportunities?
- What drives the customers to purchase solutions and services?
- What are the COVID-19 Mitigation technology & services trends?
- What is the 212 sub-markets size over the 2020-2024 period?
- What are the challenges to market penetration & growth?
To adhere to our high standards of research, as nobody can truly forecast the future of this on-going pandemic, we include in the report two scenarios:
- Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021
- Conservative scenario – assumes (among other things) that no mass vaccination will be available until July 2024
With a highly fragmented market we address the "money trail" – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:
- 54 products and services:
o COVID -19 Vaccines |
o Medical Eye Protection |
o COVID -19 Therapeutic Drugs |
o PPE Sterilization: Systems & Consumables |
o Other COVID-19 Pharma Industry Products |
o Hand & Surface Sanitizers |
o PCR Instrumentation & Software |
o Decontamination |
o Robotic PCR Systems & Software |
o Other Personal Protection Gear |
o PCR Reagents & Consumables |
o AI, Big Data & Deep Learning |
o Nose & Mouth Swabs |
o Homecare IT |
o Self-collection PCR Test Kits |
o Geo-Surveillance Systems & Services |
o Serologic Test Kits |
o E-Health |
o Standoff Thermometry |
o Blockchain Technologies |
o X-Ray Procedures |
o Other ICT |
o CT Procedures |
o Noninvasive Ventilators |
o Ultrasound Procedures |
o Invasive Mechanical Ventilators |
o Wastewater testing |
o Next Generation Ventilators |
o FDG-PET/CT Procedures o COVID-19 Waste Water Surveillance |
o COVID-19 Homecare |
o PACS & Teleradiology |
o Portable Ventilators |
o Medical PPE Gowns |
o Surge Capacity Hospitals & ICUs |
o Medical Gloves |
o Kidney Dialysis |
o Medical Face Masks |
o Extracorporeal Membrane Oxygenation Procedures |
o Medical Face Shields |
o Other Intensive Care Modalities |
o PPE Gowns Manufacturing Plants |
o PCR Systems Manufacturing Plants |
o Gloves Manufacturing Plants |
o Nose & Mouth Swabs Manufacturing Plants |
o Face Masks Manufacturing Plants |
o COVID-19 Vaccine Manufacturing Plants |
o Face Shields Manufacturing Plants |
o R&D Equipment & Consumables |
o Self-Collected PCR Test Kits Manufacturing. Plants |
o Medical Glass |
o Melt-Blown PPE Fabric Manufacturing Plants |
o Ventilators Manufacturing Plants |
o Spun-Bond PPE Fabric Manufacturing Plants |
o PCR Reagents Manufacturing Plants |
o Serological Test Kits Manufacturing Plants |
- 6 vertical markets:
- Hospitals & Surge Hospitals
- Clinical Labs
- Clinics
- Emergency Medical Services (EMS)
- Homecare & Nursing Homes
- Research Bodies
- 13 national markets:
- USA
- Canada
- UK
- Germany
- France
- Italy
- Rest of Europe
- India
- China
- South Korea
- Japan
- Rest of Asia Pacific
- ROW
- 5 regional markets:
- North America
- Latin America
- Europe
- Middle East & Africa
- Asia Pacific
- 4 revenue source markets:
- Product Sales
- Training Services
- Planning & Consulting
- Maintenance & Upgrades
For more information, or to purchase a copy, please visit us here.
About the analysts that composed this report:
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, Bio-decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices, and brings long term cooperation with the FDA and CDC as well as the EU CE and other national medical legislation agencies. As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products & services purchases. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies.
About Homeland Security Research Corp. (HSRC)
Homeland Security Research Corp. (HSRC) is an international market and technology research firm specializing in the Public Safety Industry. HSRC provides premium off-the-shelf and customized market reports on present and emerging technologies and industry expertise, enabling global clients to gain time-critical insight into business opportunities. HSRC's clients include the U.S. Congress, DHS, U.S. Army, U.S. Navy, DOD, DOT, GAO, NATO, and EU, among others, as well as government agencies in Japan, Korea, Taiwan, Israel, Canada, UK, Germany, Australia, Sweden, Finland, Singapore. With over 950 private sector clients (76% returning), including major defense and security contractors and Fortune 2000 companies, HSRC earned the reputation as the industry's Gold Standard for public safety market reports.
Washington D.C. 20004, 601 Pennsylvania Ave., NW Suite 900,
Tel: 202-455-0966, [email protected], https://homelandsecurityresearch.com
SOURCE Homeland Security Research Corp. (HSRC)
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article